
How do I evaluate what you're actually buying — in the aisle where the organ clears the products?
The kidney-supplement market is this library's most dangerous aisle, and the page's hardest truth: the 'kidney cleanse' and 'kidney support' category sells untested botanical stacks cleared by the very organ they claim to help — the modern pattern behind supplement-driven kidney injury. The honest shelf is narrow, population-divided, and physician-gated: a stone agent that's contraindicated in the failing kidney, one disease-specific fish-oil evidence base, and a vitamin whose management changes with the eGFR. This chapter teaches the eGFR border that divides the two shelves.
Citrate — physician-dosed
Omega-3 — with fat, IFOS
D3 — test-guided
The category this chapter retires
The studied stone-prevention intervention — physician-dosed, potassium-carried, and CKD-contraindicated territory. The serious option for the serious stone-former, gated by the eGFR.
~4 oz of real lemon in diluted water delivers meaningful citrate without the potassium load — the stones page's beverage, and the food-first answer for anyone whose potassium status makes the pharmacy version the wrong choice.
Label literacy in the kidney aisle has four specific jobs:
The kidney market sells to the frightened — 37 million undiagnosed and millions more told 'watch your kidney numbers.' Be highly cautious of products that: